おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Pertinax Pharma Ltd.
company
About
Pertinax Pharma Ltd. is a patent-protected, sustained release technology for chlorhexidine, a common antiseptic.
- 1 - 10
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- £400K
- Industries
- Health Care,Medical
- Founded date
- Jan 1, 2015
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Pertinax Pharma Ltd. is a patent-protected, sustained release technology for chlorhexidine, a common antiseptic. Pertinax have developed an innovative range of controlled release antimicrobial materials with applications across many industries and sectors.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
£1.26M
Pertinax Pharma Ltd. has raised a total of
£1.26M
in funding over 2 rounds. Their latest funding was raised on
Oct 11, 2018 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 11, 2018 | Series Unknown | £860K | 1 | — | — | Detail |
| Jul 4, 2016 | Seed | £400K | 1 |
Mercia Fund Managers
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Pertinax Pharma Ltd. is funded by 1 investors.
Mercia Fund Managers
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Mercia Fund Managers
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
